TY - JOUR
T1 - Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP
AU - Wang, Minyan
AU - Urenjak, Jutta
AU - Fedele, Ernesto
AU - Obrenovitch, Tihomir P.
N1 - Funding Information:
This work was supported by the Migraine Trust (London); Grant No. 127. The authors extend their thanks to A.J. Reed (Department of Biomedical Sciences, University of Bradford) and A.L. Holmes (School of Pharmacy, University of Bradford) for their technical help.
PY - 2004/4/15
Y1 - 2004/4/15
N2 - Cortical spreading depression (CSD) is a temporary disruption of local ionic homeostasis that propagates slowly across the cerebral cortex, and may contribute to the pathophysiology of stroke and migraine. Previous studies demonstrated that nitric oxide (NO) formation promotes the repolarisation phase of CSD, and this effect may be cyclic GMP (cGMP)-mediated. Here, we have examined how phosphodiesterase (PDE) inhibition, either alone or superimposed on NO synthase (NOS) inhibition, alters CSD and the associated changes in extracellular cGMP. Microdialysis probes incorporating an electrode were implanted into the frontoparietal cortex of anaesthetised rats for quantitative recording of CSD, pharmacological manipulations, and dialysate sampling for cGMP measurements. CSD was induced by cathodal electrical stimulation in the region under study by microdialysis. Extracellular cGMP increased, but only slightly, during CSD. Perfusion of either zaprinast or sildenafil through the microdialysis probe, at concentrations that inhibited both PDE5 and PDE9 (and possibly other PDE), increased significantly extracellular cGMP. Unexpectedly, these levels remained high when NOS was subsequently inhibited with N ω-nitro-L-arginine methyl ester hydrochloride (L-NAME, 1mM). The most interesting pharmacological effect on CSD was obtained with sildenafil. This drug altered neither CSD nor the subsequent characteristic effect of NOS inhibition, i.e. a marked widening of CSD. The fact that NOS inhibition still widened CSD in the presence of the high extracellular levels of cGMP associated with PDE inhibition, suggests that NO may promote CSD recovery, independently of cGMP formation.
AB - Cortical spreading depression (CSD) is a temporary disruption of local ionic homeostasis that propagates slowly across the cerebral cortex, and may contribute to the pathophysiology of stroke and migraine. Previous studies demonstrated that nitric oxide (NO) formation promotes the repolarisation phase of CSD, and this effect may be cyclic GMP (cGMP)-mediated. Here, we have examined how phosphodiesterase (PDE) inhibition, either alone or superimposed on NO synthase (NOS) inhibition, alters CSD and the associated changes in extracellular cGMP. Microdialysis probes incorporating an electrode were implanted into the frontoparietal cortex of anaesthetised rats for quantitative recording of CSD, pharmacological manipulations, and dialysate sampling for cGMP measurements. CSD was induced by cathodal electrical stimulation in the region under study by microdialysis. Extracellular cGMP increased, but only slightly, during CSD. Perfusion of either zaprinast or sildenafil through the microdialysis probe, at concentrations that inhibited both PDE5 and PDE9 (and possibly other PDE), increased significantly extracellular cGMP. Unexpectedly, these levels remained high when NOS was subsequently inhibited with N ω-nitro-L-arginine methyl ester hydrochloride (L-NAME, 1mM). The most interesting pharmacological effect on CSD was obtained with sildenafil. This drug altered neither CSD nor the subsequent characteristic effect of NOS inhibition, i.e. a marked widening of CSD. The fact that NOS inhibition still widened CSD in the presence of the high extracellular levels of cGMP associated with PDE inhibition, suggests that NO may promote CSD recovery, independently of cGMP formation.
KW - 3-isobutyl-1-methylxanthine
KW - CSD
KW - Calcium-activated potassium channels
KW - Cortical spreading depression
KW - Cyclic GMP
KW - Direct current potential
KW - IBMX
KW - K channels
KW - L-NAME
KW - cGMP
KW - dc potential
UR - http://www.scopus.com/inward/record.url?scp=1642388322&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2003.12.029
DO - 10.1016/j.bcp.2003.12.029
M3 - Article
C2 - 15041479
AN - SCOPUS:1642388322
SN - 0006-2952
VL - 67
SP - 1619
EP - 1627
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 8
ER -